Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CADI-05 |
| Synonyms | |
| Therapy Description |
CADI-05 is a Toll-like receptor-2 agonist that activates anti-tumor immune response against desmocollin-3-expressing cells, which may lead to tumor growth inhibition (PMID: 27831503). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CADI-05 | CADI 05|CADI05 | CADI-05 is a Toll-like receptor-2 agonist that activates anti-tumor immune response against desmocollin-3-expressing cells, which may lead to tumor growth inhibition (PMID: 27831503). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|